Rodbard, H W <br/><br/>
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  02 2017 
 - 189-196 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.13256  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin, Long-Acting--therapeutic use<br/>Liraglutide--therapeutic use<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Sulfonylurea Compounds--therapeutic use